Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05290194
What this trial is testing

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
RadiotherapyPD-1 InhibitorCapecitabine+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902
What this trial is testing

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Diwakar Davar 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Very early researchLooking for participantsNCT07319195
What this trial is testing

Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)

Who this might be right for
Breast Cancer
Jennifer Zhang 32
Testing effectiveness (Phase 2)Looking for participantsNCT06965231
What this trial is testing

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Who this might be right for
Melanoma of SkinAcral MelanomaStage II Melanoma
Fudan University 58
Testing effectiveness (Phase 2)UnknownNCT05007145
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 92
Testing effectiveness (Phase 2)Looking for participantsNCT07367516
What this trial is testing

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 105
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116
What this trial is testing

Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Who this might be right for
Advanced Solid TumorGynecologic Cancer
Clovis Oncology, Inc. 227
Not applicableNot Yet RecruitingNCT07350824
What this trial is testing

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

Who this might be right for
HCCMinimal Residual DiseaseRecurrence
Tongji Hospital 276
Testing effectiveness (Phase 2)UnknownNCT04860674
What this trial is testing

A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma

Who this might be right for
Gray Zone LymphomaRelapse/RecurrenceChemotherapy Effect
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)UnknownNCT03311789
What this trial is testing

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

Who this might be right for
Biliary Tract Cancer
Chinese PLA General Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07132008
What this trial is testing

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Who this might be right for
Colonic NeoplasmsNeoadjuvant TherapyImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 94
Not applicableStudy completedNCT03305380
What this trial is testing

Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Maastricht Radiation Oncology 637
Testing effectiveness (Phase 2)Study completedNCT04796194
What this trial is testing

Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma

Who this might be right for
Advanced Melanoma
Lytix Biopharma AS 23
Testing effectiveness (Phase 2)Looking for participantsNCT07410520
What this trial is testing

PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
The First Affiliated Hospital with Nanjing Medical University 50
Large-scale testing (Phase 3)Looking for participantsNCT03949231
What this trial is testing

Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University 200
Not applicableUnknownNCT04471480
What this trial is testing

TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer

Who this might be right for
ESCC
Dong Wang 90
Large-scale testing (Phase 3)Looking for participantsNCT06239727
What this trial is testing

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 593
Testing effectiveness (Phase 2)UnknownNCT04652440
What this trial is testing

Ablation Combined With PD-1 in HCC: Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT04679480
What this trial is testing

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

Who this might be right for
Basal Cell Carcinoma
Reinhard Dummer 20
Next Page